Tumor subtypes were defined according to the expression of ER, progesterone receptor (PgR), and human epidermal growth factor receptor 2 (HER2); luminal (ER+ and/or PgR+, HER2-), luminal-HER2 (ER+ and/or PgR+, HER2+), HER2-enriched (ER- and PgR-, HER2+), and triple-negative (ER-, PgR- and HER2-). This evidence concerns the gene PGR and neoplasm.